Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a

• Status: Completed
• Trial end date: 2013-01-01
• Target enrollment: 0
• Participant gender: All

Summary

Birdshot Retine choroidopathy (BRC) is a sight threatening posterior uveitis. The long term visual outcome has recently be studied showing a legal blindness to 14% at 5 years. Visual acuity is threatened by macular edema (80%), macular atrophy, and choroidal neovascularization.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assistance Publique - Hôpitaux de Paris
• Treatments: Interferon alpha-2; Interferon-alpha; Interferons; Prednisone

Criteria

Inclusion Criteria:

• Patients with Birdshot Retine choroidopathy with macular edema

• HLA A29 positive

• Work up of infection or sarcoidosis disease negative

Exclusion Criteria:

• Pregnancy

• Alcohol addiction

• Mood disturbance

• Medullar, hepatic, renal deficiency